Grant: Discovery Grants Program - Individual
University of Calgary
$41,000.00
Placental hormones and adaptability of feto-maternal physiology
FY 2016-17
Summary
The life history of placental mammals involves a complex interplay between mother and her young within the uterus. The placenta transports nutrients and gases but the mother undergoes profound adaptations in her metabolic, brain and behavior, and blood systems during gestation to support fetal growth. Hormones from the placenta are often viewed as regulators in the allocation of resources between fetus and mother, but the complexity of the system is only becoming clear from modern genomics - there are dozens of hormones expressed by the placenta but they are rapidly evolving. The human placenta expresses 80 polypeptide hormone genes, four of which are placenta-specific arising from duplication of the Growth Hormone (GH) gene while the other 76 genes reflect evolution of placenta-specific enhancers or promoters in canonical hormone genes otherwise expressed in brain, kidney and fat. The mouse placenta expresses 40 polypeptide hormone genes, 22 of which arose through duplication of the Prolactin (Prl) gene (the GH gene is not duplicated in mice). In sheep, both the GH and Prl genes are duplicated whereas neither gene is duplicated in dogs. Despite the genome differences, humans, mice, sheep and dogs share maternal physiological adaptations. Our hypothesis is that placental hormones drive metabolic, behavioral and cardiovascular adaptations directly or through interaction with other endocrine organs. In support of this, loss and gain of function experiments in mice have shown that the Phlda2 gene regulates endocrine cell number in the placenta, and Phlda2 expression differences are associated with fetal growth rate in mice, humans and cattle. Fetal growth is an important trait since animals or humans born with low birth weight have higher risks of neonatal death, developmental delay and risk of cardiovascular and metabolic disease later in life (developmental origins of adult health and disease).
The long-term objective of my program is to define the evolution of placental hormones and their contributions to pregnancy outcome. As key background, we developed mice lacking a large family of placenta-specific Prolactin-related hormones (PPRH) and found that the mice have phenotypes consistent with functions of hormones that are expressed in the human placenta, regulating maternal metabolic, cardiovascular and behavioral adaptations to pregnancy. Our data show these hormones are important for fetal growth but also protect the health of the mother during pregnancy and their expression adapts to changes in maternal diet.
The specific aims for the next 5 years are to:
1) Define pregnancy hormone network and correlate with gestation across species
2) Attribute specific placental hormones to maternal adaptations to pregnancy
3) Determine the ability of placental hormone-deficient mice to adapt to maternal stress
4) Describe placental hormone changes in IUGR and poor nutrition in non-rodent species
Program
Discovery Grants Program - Individual
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2016-04063
Name nom
Cross, James
Department département
Veterinary Medicine, Faculty of - Veterinary Medicine, Faculty of
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
41000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5505
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal reproduction
Research subject fr
Reproduction animale
Partie
1
Nb partie
5
Application title
Placental hormones and adaptability of feto-maternal physiology
Keyword
NSERC
Application summary
The life history of placental mammals involves a complex interplay between mother and her young within the uterus. The placenta transports nutrients and gases but the mother undergoes profound adaptations in her metabolic, brain and behavior, and blood systems during gestation to support fetal growth. Hormones from the placenta are often viewed as regulators in the allocation of resources between fetus and mother, but the complexity of the system is only becoming clear from modern genomics - there are dozens of hormones expressed by the placenta but they are rapidly evolving. The human placenta expresses 80 polypeptide hormone genes, four of which are placenta-specific arising from duplication of the Growth Hormone (GH) gene while the other 76 genes reflect evolution of placenta-specific enhancers or promoters in canonical hormone genes otherwise expressed in brain, kidney and fat. The mouse placenta expresses 40 polypeptide hormone genes, 22 of which arose through duplication of the Prolactin (Prl) gene (the GH gene is not duplicated in mice). In sheep, both the GH and Prl genes are duplicated whereas neither gene is duplicated in dogs. Despite the genome differences, humans, mice, sheep and dogs share maternal physiological adaptations. Our hypothesis is that placental hormones drive metabolic, behavioral and cardiovascular adaptations directly or through interaction with other endocrine organs. In support of this, loss and gain of function experiments in mice have shown that the Phlda2 gene regulates endocrine cell number in the placenta, and Phlda2 expression differences are associated with fetal growth rate in mice, humans and cattle. Fetal growth is an important trait since animals or humans born with low birth weight have higher risks of neonatal death, developmental delay and risk of cardiovascular and metabolic disease later in life (developmental origins of adult health and disease).
The long-term objective of my program is to define the evolution of placental hormones and their contributions to pregnancy outcome. As key background, we developed mice lacking a large family of placenta-specific Prolactin-related hormones (PPRH) and found that the mice have phenotypes consistent with functions of hormones that are expressed in the human placenta, regulating maternal metabolic, cardiovascular and behavioral adaptations to pregnancy. Our data show these hormones are important for fetal growth but also protect the health of the mother during pregnancy and their expression adapts to changes in maternal diet.
The specific aims for the next 5 years are to:
1) Define pregnancy hormone network and correlate with gestation across species
2) Attribute specific placental hormones to maternal adaptations to pregnancy
3) Determine the ability of placental hormone-deficient mice to adapt to maternal stress
4) Describe placental hormone changes in IUGR and poor nutrition in non-rodent species